Suppression of par-4 protects human renal proximal tubule cells from apoptosis induced by oxidative stress

Nephron - Experimental Nephrology

Volumn 117, Issue 3, 2011, Pages

  Sun, Bin ^a   Lu, Chao ^b   Zhou, Guo Ping ^b   Xing, Chang Ying ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Human renal proximal tubule cells; Oxidative stress; PI3K Akt signal transduction; Prostate apoptosis response factor 4; siRNA experiments

Indexed keywords

CASPASE 3; HYDROGEN PEROXIDE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEINASE ACTIVATED RECEPTOR 4; SMALL INTERFERING RNA; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KIDNEY PROXIMAL TUBULE; KIDNEY PROXIMAL TUBULE CELL; KIDNEY TUBULE CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL PROTECTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASE 3; DOWN-REGULATION; HUMANS; HYDROGEN PEROXIDE; KIDNEY TUBULES, PROXIMAL; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77956123792     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320594     Document Type: Article

References (35)

1. Cachofeiro V, Goicochea M, de Vinuesa SG, Oubiña P, Lahera V, Luño J: Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl 2008;111: S4-S9.
2. Cowley AW: Renal medullary oxidative stress, pressure natriuresis, and hypertension. Hy pertension 2008;52:777-786.
3. Ha H, Hwang IA, Park JH, Lee HB: Role of reactive oxygen species in the pathogenesis of diabetic nephropathy. Diabetes Res Clin Pract 2008;82(suppl 1): S42-S45.
4. Andreoli SP, Mallett CP, McAteer JA, Kempson SA, Fineberg N: Epidermal growth factor accelerates recovery of LLC-PK1 cells following oxidant injury. In Vitro Cell Dev Biol Anim 1998;34:824-830. (Pubitemid 29077067)
5. Peraza MA, Cromey DW, Carolus B, Carter DE, Gandolfi AJ: Morphological and functional alterations in human proximal tubular cell line induced by low level inorganic arsenic: evidence for targeting of mitochondria and initiated apoptosis. J Appl Toxicol 2006;26:356-367. (Pubitemid 44064935)
6. Filiopoulos V, Hadjiyannakos D, Takouli L, Metaxaki P, Sideris V, Vlassopoulos D: Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis. Int J Artif Organs 2009;32:872-882.
7. Ember A, Clark JS, Varjas T, Kiss I, Ember I, Baliga R, Arany I: The plant-derived natural compound Flavin 7 attenuates oxidative stress in cultured renal proximal tubule cells. In Vivo 2009;23:975-978.
8. Yun Y, Duan WG, Chen P, Wu HX, Shen ZQ, Qian ZY, Wang DH: Ischemic postconditioning modified renal oxidative stress and lipid peroxidation caused by ischemic reperfusion injury in rats. Transplant Proc 2009;41:3597-3602.
9. Pérez-Rojas JM, Cruz C, García-López P, Sánchez-González DJ, Martínez-Martínez CM, Ceballos G, Espinosa M, Meléndez-Zajgla J, Pedraza-Chaverri J: Renoprotection by α-mangostin is related to the attenuation in renal oxidative/nitrosative stress induced by cisplatin nephrotoxicity. Free Radic Res 2009;43:1122-1132.
10. Devalaraja-Narashimha K, Singaravelu K, Padanilam BJ: Poly (ADP-ribose) polymerase-mediated cell injury in acute renal failure. Pharmacol Res 2005;52:44-59. (Pubitemid 40725599)
11. Versteilen AM, Di Maggio F, Leemreis JR Groeneveld AB, Musters RJ, Sipkema P: Molecular mechanisms of acute renal failure following ischemia/reperfusion. Int J Artif Organs 2004;27:1019-1029.
12. Padanilam BJ: Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis. Am J Physiol Renal Physiol 2003;284: F608-F627. (Pubitemid 36336968)
13. Gurumurthy S, Rangnekar VM: Par-4 inducible apoptosis in prostate cancer cells. J Cell Biochem 2004;91:504-512.
14. Fleischer A, Ghadiri A, Dessauge F, Duhamel M, Rebollo MP, Alvarez-Franco F, Rebollo A: Modulating apoptosis as a target for effective therapy. Mol Immunol 2006;43:1065-1079. (Pubitemid 43063161)
15. Ranganathan P, Rangnekar VM: Regulation of cancer cell survival by Par-4. Ann NY Acad Sci 2005;1059:76-85. (Pubitemid 43211613)
16. Culmsee C, Landshamer S: Molecular insights into mechanisms of the cell death program: role in the progression of neurodegenerative disorders. Curr Alzheimer Res 2006;3:269-283. (Pubitemid 44351472)
17. Lu C, Chen JQ, Zhou GP, Wu SH, Guan YF, Yuan CS: Multimolecular complex of Par-4 and E2F1 binding to Smac promoter contributes to glutamate-induced apoptosis in human bone mesenchymal stem cells. Nucleic Acids Res 2008;36:5021-5032.
18. Lee TJ, Lee JT, Kim SH, Choi YH, Song KS, Park JW, Kwon TK: Overexpression of Par-4 enhances thapsigargin-induced apoptosis via down-regulation of XIAP and inactivation of Akt in human renal cancer cells. J Cell Biochem 2008;103:358-368.
19. Sheng S, Qiao M, Pardee AB: Metastasis and AKT activation. J Cell Physiol 2009;5218:451-454.
20. Weichhart T, Säemann MD: The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications. Ann Rheum Dis 2008;67(suppl 3): iii70-74.
21. Pitt SC, Chen H: The phosphatidylinositol 3-kinase/Akt signaling pathway in medullary thyroid cancer. Surgery 2008;144:721-724.
22. Assinder SJ, Dong Q, Kovacevic Z, Richardson DR: The TGF-β, PI3K/Akt and PTEN pathways: established and proposed biochemical integration in prostate cancer. Biochem J 2009;417:411-421.
23. De Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH: Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 2001;12:993-1000. (Pubitemid 32378340)
24. Flyvbjerg A, Dagnaes-Hansen F, De Vriese AS, Schrijvers BF, Tilton RG, Rasch R: Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 2002;551:3090-3094.
25. Cooper ME, Vranes D, Youssef S, Stacker SA, Cox AJ, Rizkalla B, Casley DJ, Bach LA, Kelly DJ, Gilbert RE: Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 1999;48:2229-2239. (Pubitemid 29521855)
26. Tsuchida K, Makita Z, Yamagishi S, Atsumi T, Miyoshi H, Obara S, Ishida M, Ishikawa S, Yasumura K, Koike T: Suppression of transforming growth factor β and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195. Diabetologia 1999;42:579-588. (Pubitemid 29196009)
27. Pore N, Liu S, Shu HK, Li B, Haas-Kogan D, Stokoe D, Milanini-Mongiat J, Pages G, ORourke DM, Bernhard E, Maity A: Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism. Mol Biol Cell 2004;15:4841-4853. (Pubitemid 39392201)
28. 2 and p38 (SAPK). Free Radic Biol Med 2006;41:213-221. (Pubitemid 43928493)
29. Porter AG, Jänicke RU: Emerging roles of caspase-3 in apoptosis. Cell Death Differ 1999;6:99-104. (Pubitemid 29082297)
30. Villegas G, Lange-Sperandio B, Tufro A: Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells. Kidney Int 2005;67:449-457. (Pubitemid 40139836)
31. Liang Z, Brooks J, Willard M, Liang K, Yoon Y, Kang S, Shim H: CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway. Biochem Biophys Res Commun 2007;359:716-722. (Pubitemid 46908803)
32. 2) - induced peroxidation of microsomal membrane lipids and DNA damage. Teratog Carcinog Mutagen 2003; suppl 1:151-160. (Pubitemid 36277892)
33. Diaz-Meco MT, Moscat J: Akt regulation and lung cancer: a novel role and mechanism of action for the tumor suppressor Par-4. Cell Cycle 2008;7:2817-2820.
34. Joshi J, Fernandez-Marcos PJ, Galvez A, Amanchy R, Linares JF, Duran A, Pathrose P, Leitges M, Cañamero M, Collado M, Salas C, Serrano M, Moscat J, Diaz-Meco MT: Par-4 inhibits Akt and suppresses Ras-induced lung tumorigenesis. EMBO J 2008;27:2181-2193.
35. Joshi J, Fernandez-Marcos PJ, Galvez A, Amanchy R, Linares JF, Duran A, Pathrose P, Leitges M, Cañamero M, Collado M, Salas C, Serrano M, Moscat J, Diaz-Meco MT: Par-4 inhibits Akt and suppresses Ras-induced lung tumorigenesis. EMBO J 2008;27:2181-2193.